Analyst Ratings News 13 December 2025

Arcus Biosciences (RCUS) Stock News, Forecasts and Analyst Targets — Dec. 14, 2025 Update

Arcus Biosciences, Inc. (NYSE: RCUS) is ending the weekend under a bright—and volatile—spotlight after a major clinical-program reset triggered a sharp Friday selloff. As of Sunday, December 14, 2025, the last reported close was $21.53, down 14.36% from the prior

14 December 2025

Analyst Ratings·Biotech Stocks·Financial News·Investment Analysis·Stock Market

RH Stock News & Forecast (NYSE:RH) on Dec. 14, 2025: Q3 FY2025 Earnings, Guidance Reset, and New Analyst Price Targets

Published: Sunday, December 14, 2025 (U.S. markets last closed Friday, Dec. 12) RH (NYSE:RH)—the luxury home furnishings and lifestyle retailer—heads into the new week with investors digesting a busy stretch of catalysts: a fresh quarterly report, updated full‑year outlook, and

14 December 2025

Analyst Ratings·Earnings Reports·Financial News·Investment Analysis·Stock Market

CCC Intelligent Solutions Holdings Inc. Stock (NASDAQ: CCC): $500M Buyback, Debt-Funded ASR, Analyst Price Targets, and What’s Next (Dec. 14, 2025)

CCC Intelligent Solutions Holdings Inc. shares are in focus this weekend after the company unveiled a major capital-return move that instantly reshaped the near‑term narrative around the stock: a fresh $500 million share repurchase authorization, anchored by a $300 million

14 December 2025

Analyst Ratings·Buybacks·Investment Strategies·Nasdaq·Stock Analysis

Immunovant (IMVT) Stock News and Forecast for Dec. 14, 2025: $550M Financing Closes, Roivant Buys $350M, Analysts Update Targets

Immunovant, Inc. (NASDAQ: IMVT) stock is closing out the week in focus after the company completed a major equity raise designed to bolster funding for its autoimmune pipeline—while its controlling shareholder, Roivant Sciences, stepped in as the largest buyer. As

14 December 2025

Analyst Ratings·Biotechnology·Financial Analysis·Investment Strategies·Stock Market News

Fermi Inc. (FRMI) Stock News Today: Shares Sink After $150M Project Matador Funding Deal Ends — Forecasts, Analyst Targets, and What’s Next (Dec. 14, 2025)

Fermi Inc. (NASDAQ: FRMI) stock plunged after a prospective tenant terminated a $150M construction funding agreement tied to Project Matador. Here’s the latest news, forecasts, and analyst outlook as of Dec. 14, 2025. Published/Updated: Sunday, December 14, 2025 (markets closed;

14 December 2025

Analyst Ratings·Company Analysis·Financial Forecasts·Investment Insights·Stock Market News

Sandisk (SNDK) Stock News Today: Downgrade-Driven Selloff, Updated Analyst Forecasts, and What Investors Watch Next (Dec. 14, 2025)

Sandisk stock (NASDAQ: SNDK) heads into the Dec. 15 open after a sharp Friday drop. Here’s what drove the move, the latest Wall Street targets, and key catalysts for 2026. MarketScreener Sandisk Corporation (Nasdaq: SNDK) is ending the weekend under

14 December 2025

Analyst Ratings·Financial News·Investing·Stock Market·Tech Stocks

Ondas Holdings (ONDS) Stock: Key News, Price Action, Analyst Targets, and What to Watch Next Week (Updated Dec. 14, 2025)

Updated: December 14, 2025 — Ondas Holdings Inc. (NASDAQ: ONDS) heads into the new week after a high-volume, high-volatility stretch that’s becoming typical for the stock in late 2025: big contract headlines, aggressive expansion moves, and fresh SEC-linked developments colliding

14 December 2025

Analyst Ratings·Financial Updates·Investment Tips·Market News·Stocks

Imperial Brands PLC (IMB.L) Stock This Week and Week Ahead: Buybacks, Debt Call, Dividend Calendar, and Analyst Targets (Updated 14.12.2025)

Updated Sunday, 14 December 2025 (markets last closed Friday, 12 December 2025). Imperial Brands PLC shares ended the week on the back foot after touching a fresh 52‑week high earlier in the week, with investors weighing a familiar mix for

14 December 2025

Analyst Ratings·Buybacks·Dividends·Investment Strategies·Stock Analysis

RELX PLC Stock (REL) This Week: Buyback Update, Analyst Upgrades, and the Week-Ahead Catalysts (Updated 14 December 2025)

Updated: Sunday, 14 December 2025 (markets closed; last close Friday, 12 December 2025) RELX PLC (LSE: REL, NYSE: RELX) heads into the new week with a familiar “quality compounder” narrative—steady cash generation, a subscription-heavy model, and a growing analytics footprint—now

14 December 2025

Analyst Ratings·Financial News·Investment Analysis·Stock Market

AbbVie Stock Outlook (ABBV): Weekly Recap, Fresh Analyst Upgrades, and the Week-Ahead Setup (Updated Dec. 12, 2025)

AbbVie Inc. (NYSE: ABBV) ended the week of Dec. 8–12, 2025 near $223, after a choppy stretch that featured two notable Wall Street moves—an HSBC upgrade and a Morgan Stanley price-target hike—alongside ongoing headlines tied to AbbVie’s oncology and neuroscience

14 December 2025

Analyst Ratings·Investment Strategies·Pharma Industry·Stock Market·Weekly Recap

Coca-Cola Stock (KO) Outlook: CEO Transition, Dividend Week, Analyst Targets — Updated Dec. 12, 2025

Updated: Friday, December 12, 2025 (U.S. market close)Company: The Coca-Cola Company (NYSE: KO) Coca-Cola stock ended the week near the $70 level after a choppy stretch of trading that included a sharp one-day dip and a strong Friday rebound. Investors

14 December 2025

Analyst Ratings·CEO Changes·Dividend Investing·Market Outlook·Stock Analysis

RTX Stock Outlook: Why RTX Shares Rose This Week, Fresh News, Analyst Targets, and What to Watch Next Week (Updated Dec. 12, 2025)

Updated: December 12, 2025 (after U.S. market close) RTX Corporation (NYSE: RTX) ended Friday, Dec. 12, 2025, at $178.66, up 0.70% on the day, with shares trading between $176.63 and $179.45 and volume of about 6.44 million. Investing That finish

13 December 2025

Analyst Ratings·Company News·Financial Forecasts·Investing·Stock Market

Analyst Ratings News 13 December 2025 - 14 December 2025